Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 110

Results For "MP"

9930 News Found

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


FDA pushes forward on gene-editing therapies with new safety roadmap
Biotech | April 20, 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases


Philips wins FDA nod for AI-powered spectral CT system Verida
Medical Device | April 20, 2026

Philips wins FDA nod for AI-powered spectral CT system Verida

At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine


Merck bags EU nod for infant RSV protection in major public health milestone
News | April 19, 2026

Merck bags EU nod for infant RSV protection in major public health milestone

ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose


Takara Bio and Resistomap forge deal to speed up global fight against superbugs
News | April 19, 2026

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence


ANRF CEO calls for excellence-led innovation at SRMIST Research Day
R&D | April 18, 2026

ANRF CEO calls for excellence-led innovation at SRMIST Research Day

Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe